IPO registrations (S-1, F-1) · Registrants
MedAvail Holdings, Inc.
- SEC CIK
- 1402479 · filings on EDGAR ↗
- Former names
- MYOS RENS TECHNOLOGY INC. (2016–2020); MYOS Corp (2012–2016); Atlas Therapeutics Corp (2010–2012); Rough Tide Marine Operations, Inc. (2010–2010); Marvin's Place, Inc. (2007–2010)
- Registration
- Form S-1, first filed 2012-08-06, last 2021-05-13; 3 initial registrations, 6 amendments
- Outcome
- Declared effective 2012-11-09
- Industry (SIC)
- Retail-Drug Stores and Proprietary Stores 5912
- Incorporated in
- DE
- Business address
- 4720 E COTTON GIN LOOP, SUITE 220, Phoenix, AZ 85040
- EIN
- 90-0772394
- EDGAR entity type
- operating
- Insiders and CEO pay
- MedAvail Holdings, Inc. on the corporate pages
Offering terms
- Shares offered
- 15,193,972
- Listing
- Nasdaq under the symbol MDVL
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: MEDAVAIL HOLDINGS, INC. EXACT (EIN (EXACT))
- Form D issuer: MedAvail Holdings, Inc. EXACT (CIK (EXACT))
- SEC filer: Atlas Therapeutics Corp EXACT (CIK (EXACT))
- Person page: Carlon M Colker Md Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer,TenPercentOwner))
- Person page: Christopher C Dewey Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: David J Matlin Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner))
Filings 22
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2012-08-06 | S-1 | S-1 (registration) | MYOS Corp | 0001213900-12-004209 ↗ |
| 2012-08-17 | S-1/A | S-1/A (amendment) | MYOS Corp | 0001213900-12-004728 ↗ |
| 2012-09-25 | S-1/A | S-1/A (amendment) | MYOS Corp | 0001213900-12-005384 ↗ |
| 2012-10-11 | S-1/A | S-1/A (amendment) | MYOS Corp | 0001213900-12-005594 ↗ |
| 2012-11-05 | S-1/A | S-1/A (amendment) | MYOS Corp | 0001213900-12-005925 ↗ |
| 2012-11-09 | EFFECT | EFFECT (declared effective) | MYOS Corp | 9999999995-12-003209 ↗ |
| 2014-04-25 | S-1 | S-1 (registration) | MYOS Corp | 0001213900-14-002676 ↗ |
| 2014-05-09 | S-1/A | S-1/A (amendment) | MYOS Corp | 0001213900-14-003067 ↗ |
| 2014-05-14 | EFFECT | EFFECT (declared effective) | MYOS Corp | 9999999995-14-001479 ↗ |
| 2014-10-28 | EFFECT | EFFECT (declared effective) | MYOS Corp | 9999999995-14-003163 ↗ |
| 2018-05-15 | EFFECT | EFFECT (declared effective) | MYOS RENS TECHNOLOGY INC. | 9999999995-18-001256 ↗ |
| 2018-06-29 | EFFECT | EFFECT (declared effective) | MYOS RENS TECHNOLOGY INC. | 9999999995-18-001674 ↗ |
| 2019-06-03 | EFFECT | EFFECT (declared effective) | MYOS RENS TECHNOLOGY INC. | 9999999995-19-001252 ↗ |
| 2020-04-30 | EFFECT | EFFECT (declared effective) | MYOS RENS TECHNOLOGY INC. | 9999999995-20-000936 ↗ |
| 2020-10-15 | EFFECT | EFFECT (declared effective) | MYOS RENS TECHNOLOGY INC. | 9999999995-20-002855 ↗ |
| 2021-04-19 | S-1 | S-1 (registration) | MedAvail Holdings, Inc. | 0001628280-21-007171 ↗ |
| 2021-05-13 | S-1/A | S-1/A (amendment) | MedAvail Holdings, Inc. | 0001628280-21-010049 ↗ |
| 2021-05-14 | EFFECT | EFFECT (declared effective) | MedAvail Holdings, Inc. | 9999999995-21-001954 ↗ |
| 2022-06-24 | EFFECT | EFFECT (declared effective) | MedAvail Holdings, Inc. | 9999999995-22-001881 ↗ |
| 2022-08-26 | EFFECT | EFFECT (declared effective) | MedAvail Holdings, Inc. | 9999999995-22-002517 ↗ |
| 2022-08-26 | EFFECT | EFFECT (declared effective) | MedAvail Holdings, Inc. | 9999999995-22-002518 ↗ |
| 2022-10-20 | EFFECT | EFFECT (declared effective) | MedAvail Holdings, Inc. | 9999999995-22-003092 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-05-13 | S-1/A | registration statement | 15,193,972 | - | Nasdaq MDVL | 0 | primary document; shares headline | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Bernstein Jeffrey L. | Director,Officer | CEO and President | 2 | 2011 | |
| Colker Carlon M | Officer,TenPercentOwner | Chief Med Off and Exec VP | 1 | 2011 | person page Fuzzy |
| DiVenuto Janine | TenPercentOwner | 3 | 2011–2012 | ||
| Hariri Robert J | Director; Director,TenPercentOwner; TenPercentOwner | 23 | 2011–2020 | ||
| Aronne Louis J. | Director | 11 | 2011–2020 | ||
| Diamandis Peter | Director | 6 | 2011–2015 | ||
| Levy Peter | Officer | COO & Executive VP; COO; Executive VP; President; President and COO | 6 | 2012–2015 | |
| Aldrin Buzz | Director | 5 | 2012–2015 | ||
| Einhorn Andrew J. | Officer | Chief Financial Officer | 1 | 2012 | |
| Fleischer Glen R. | Officer; Other | Chief Executive Officer | 3 | 2013 | |
| Srivastava Sapna | Director | 7 | 2013–2015 | ||
| DeFreitas Carl | Officer | Chief Financial Officer; Interim CFO | 4 | 2013–2014 | |
| Ashton Robert C. Jr. | Officer | Chief Medical Officer | 2 | 2014–2015 | |
| PECHOCK CHRISTOPHER | Director | 9 | 2014–2020 | ||
| DosSantos Joseph | Officer | CFO; Chief Financial Officer; Interim President and CFO | 4 | 2014–2015 | |
| Venter John Craig | Director | 3 | 2014–2015 | ||
| Toussaint Kenrick Bryce | Officer | Chief Executive Officer | 2 | 2015 | |
| LEVINE JACK | Director | 1 | 2016 | ||
| MANDEL VICTOR E | Director | 5 | 2016–2020 | ||
| Nosta John | Director | 4 | 2016–2019 | ||
| LYU ZHENGGUANG | Director | 6 | 2016 | ||
| REN REN | Director,TenPercentOwner | 2 | 2016 | ||
| RENS Agriculture Science & Technology Co, Ltd | TenPercentOwner | 1 | 2016 | ||
| RENS Technology Inc | TenPercentOwner | 1 | 2016 | ||
| ZHAO GUIYING | Director | 1 | 2016 | ||
| Zhou Bin | Director | 1 | 2016 | ||
| Mannello Joseph | Director; Director,Officer; Director,Officer,TenPercentOwner | Chief Executive Officer; Interim CEO | 15 | 2016–2020 | |
| Zaltas Eric | Director | 2 | 2018–2020 | ||
| MATLIN DAVID J | TenPercentOwner | 2 | 2019–2020 | person page Fuzzy | |
| Dewey Christopher C | Director | 3 | 2019–2020 | person page Fuzzy | |
| Ponte Andrew Joel | Director | 3 | 2020 | ||
| Ciesielski Helen | Director | 2 | 2020–2022 | ||
| Ferguson Ryan | Officer | Chief Financial Officer | 3 | 2020–2021 | |
| Gradwell Gerald | Director | 5 | 2020–2022 | ||
| Kilroy Edwin | Director,Officer | Chief Executive Officer | 4 | 2020–2022 | |
| Kramer Michael R | Director | 5 | 2020–2023 | ||
| Mackay Fraser | Officer | Chief Information Officer | 2 | 2020 | |
| Misloski Will | Officer | Chief Marketing Officer | 3 | 2020–2021 | |
| Prezioso Neil | Officer | Chief Pharmacy Officer | 3 | 2020–2021 | |
| Rawlins Dave | Officer | Chief Commercial Officer | 2 | 2020 | |
| Stettin Glen D. | Director | 5 | 2020–2023 | ||
| Faulkner Robert C. | Director | 2 | 2020–2024 | ||
| Green Jeremy | Director,TenPercentOwner | 5 | 2020–2023 | ||
| Redmile Group, LLC | Director,TenPercentOwner | 5 | 2020–2023 | ||
| van Hamel Platerink Gerard | Director | 2 | 2020–2022 | ||
| ABG Management Ltd. | TenPercentOwner | 10 | 2020–2023 | ||
| ABG-WTT Global Life Science Capital Partners GP, L.P. | TenPercentOwner | 10 | 2020–2023 | ||
| ABG-WTT Global Life Science Capital Partners GP Ltd | TenPercentOwner | 10 | 2020–2023 | ||
| ABG WTT-MedAvail Ltd | TenPercentOwner | 10 | 2020–2023 | ||
| Ally Bridge Group (NY) LLC | TenPercentOwner | 10 | 2020–2023 | ||
| Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. | TenPercentOwner | 10 | 2020–2023 | ||
| Ally Bridge MedAlpha Management GP, LLC | TenPercentOwner | 7 | 2020–2021 | ||
| Ally Bridge MedAlpha Management L.P. | TenPercentOwner | 7 | 2020–2021 | ||
| Ally Bridge MedAlpha Master Fund L.P. | TenPercentOwner | 10 | 2020–2023 | ||
| Yu Fan | TenPercentOwner | 10 | 2020–2023 | ||
| Seabaugh Ramona | Officer | Chief Financial Officer | 8 | 2021–2023 | |
| Doerr Mark Edward | Director,Officer | Chief Executive Officer | 5 | 2022–2023 | |
| Johnson Paul D | Director | 4 | 2022–2023 | ||
| MCGRAW LAURIE | Director | 4 | 2022–2023 | ||
| Hess Steven | Officer | Executive Vice President | 2 | 2022 | |
| RedCo II Master Fund, L.P. | Director,TenPercentOwner | 4 | 2022–2023 | ||
| ALYESKA FUND GP, LLC | TenPercentOwner | 1 | 2022 | ||
| ALYESKA INVESTMENT GROUP, LLC | TenPercentOwner | 1 | 2022 | ||
| Alyeska Investment Group, L.P. | TenPercentOwner | 1 | 2022 | ||
| ALYESKA INVESTMENTS, LLC | TenPercentOwner | 1 | 2022 | ||
| Alyeska Master Fund, L.P. | TenPercentOwner | 1 | 2022 | ||
| PAREKH ANAND | TenPercentOwner | 1 | 2022 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2022-04-19 | MedAvail Holdings, Inc. | Pharmaceuticals | $79,411,753 | $39,999,996 | 9 | 1 |
| 2014-02-06 | MYOS Corp | Biotechnology | $5,500,000 | $4,735,000 | 32 | 1 |
| 2012-02-24 | Atlas Therapeutics Corp | Other Health Care | $1,500,000 | $725,000 | 6 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | MEDAVAIL HOLDINGS, INC. | AZ | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Form D issuer | MedAvail Holdings, Inc. | AZ | Form D private offerings | CIK (EXACT) |
| SEC filer | MedAvail Holdings, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Form 5500 plan sponsor | MEDAVAIL HOLDINGS, INC. | EIN (EXACT) | ||
| Person page | Carlon M Colker Md | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer,TenPercentOwner) | |
| Person page | Christopher C Dewey | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | David J Matlin | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Retail-Drug Stores and Proprietary Stores, AZ first:
- CLStv Corp. 2H
- CAREMARK RX INC AL
- ENVISION DEVELOPMENT CORP /FL/ CA
- HEALTHCENTRAL COM CA
- MORE COM INC CA
- BOLDFACE GROUP, INC. CA
- Flowerkist Skin Care & Cosmetics, Inc. CA
- TREES Corp (Colorado) CO
- CHINA JO-JO DRUGSTORES, INC. F4
- China Nepstar Chain Drugstore Ltd. F4
In other datasets, the same topic (Retail) in AZ:
- Form D issuer: Adaptive Supplements Inc. (Form D private offerings)
Interests: Retail-Drug Stores and Proprietary Stores · Retail